- Record: found
- Abstract: not found
- Article: not found
Efficacy and safety of teclistamab (tec), a B-cell maturation antigen (BCMA) x CD3 bispecific antibody, in patients (pts) with relapsed/refractory multiple myeloma (RRMM) after exposure to other BCMA-targeted agents
C Touzeau, AY Krishnan, P. MOREAU, Cyrille Touzeau, Amrita Krishnan, Philippe Moreau, Aurore Perrot, Saad Zafar Usmani, Salomon Manier, Michele Cavo, Carmen Martínez-Chamorro, Ajay K Nooka, Thomas Martin, Lionel Karlin, Xavier Leleu, Nizar J. Bahlis, Britta Besemer, Lixia Pei, Raluca I. Verona, Suzette Girgis, Clarissa M. Uhlar, Rachel Kobos, Alfred Garfall, A Perrot, SZ Usmani, S. Manier, A Krishnan
2022
Read this article at
ScienceOpenPublisher
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.